Type 1 Diabetes

Children with presymptomatic type 1 diabetes who had COVID-19 experienced higher rates of type 1 diabetes diagnoses than those who did not have COVID-19, according to recently published data.

An immunotherapy to treat type 1 diabetes for people with the human leukocyte antigen DR3-DQ2 genotype received its second fast-track designation from the FDA, according to a company press release.

Researchers found that adults with overweight or obesity lost more weight with tirzepatide than semaglutide in a head-to-head comparison of the medications using electronic medical records data.

A new drug application for sotagliflozin as an adjunct to insulin therapy for adults with type 1 diabetes and chronic kidney disease has been resubmitted to the FDA, according to a press release.

Children with presymptomatic type 1 diabetes progressed more quickly to type 1 diabetes after having COVID-19, according to a research letter published in JAMA.

The FDA declined to approve once-weekly basal insulin icodec for the treatment of diabetes and is requesting more information from Novo Nordisk, according to a company press release.

More than one in five adults in the U.S. with type 1 diabetes also have chronic kidney disease, according to findings from a brief report published in Diabetes Care.

Teva Pharmaceuticals launched the first generic GLP-1 receptor agonist, liraglutide 1.8 mg, for patients aged 10 years or older with type 2 diabetes.

CHICAGO — For adults with type 1 diabetes, the Mediterranean and DASH diets could help reduce the risk for CVD, according to research presented at NUTRITION.